Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Terminated × Bone Neoplasms × Diathermy × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Uterine Cervical Neoplasms 2 Salivary Gland Adenoma, Pleomorphic 1 Prostatic Neoplasms 1 Locally Advanced Rectal Cancer 1 Hemorrhage 1 Carcinoma, Hepatocellular 1 Breast Neoplasms 1 Bone Neoplasms 1

Interventions

Cyclophosphamide 3 Zoledronic Acid 2 Vincristine 2 Tranexamic Acid 2 Temozolomide 2 Magnetic Resonance Spectroscopy 2 Irinotecan 2 Ibandronic Acid 2 Etoposide 2 Doxorubicin 2 samarium Sm-153 lexidronam 1 robatumumab 1 pegfilgrastim 1 eltrombopag 1 delta 24-sterol reductase 1 Sodium Pertechnetate Tc 99m 1 Sodium Chloride 1 Samarium 1 Radiation 1 Pregabalin 1 Plicamycin 1 Neutrons 1 Ifosfamide 1 Histocompatibility Testing 1 Guanabenz 1 Gemcitabine 1 Fluoridation 1 Fibrin Tissue Adhesive 1 Etanercept 1 Diathermy 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02153593 2016-09-20

TRANEXTUM

Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau

Phase 3 Terminated

Bone Neoplasms, Hemorrhage

Data powered by HemOnc (CC BY 4.0) Colophon ⚡